Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Paroxetine (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Citalopram (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Fluoxetine (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Fluvoxamine (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Selective serotonin re-uptake inhibitor poisoning |
Causative agent (attribute) |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
1 |
Sertraline poisoning |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Accidental sertraline poisoning |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Intentional sertraline poisoning |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
intoxication par la sertraline d'intention indéterminée |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Nefazodone poisoning |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Accidental nefazodone poisoning |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Intentional nefazodone poisoning |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Nefazodone poisoning of undetermined intent |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Selective serotonin re-uptake inhibitor adverse reaction |
Causative agent (attribute) |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
1 |
Sertraline adverse reaction (disorder) |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Nefazodone adverse reaction |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Allergy to selective serotonin re-uptake inhibitor (finding) |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Allergy to sertraline |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Allergy to nefazodone |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Selective serotonin re-uptake inhibitor overdose |
Causative agent (attribute) |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
1 |
Sertraline overdose |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Accidental sertraline overdose |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Intentional sertraline overdose |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
surdose de sertraline d'intention indéterminée |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Nefazodone overdose |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Accidental nefazodone overdose |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Intentional nefazodone overdose (disorder) |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Nefazodone overdose of undetermined intent |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Product containing sertraline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Product containing precisely sertraline 50 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Product containing precisely sertraline 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Product containing selective serotonin re-uptake inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
1 |
Sertraline hydrochloride 20mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Sertraline hydrochloride 25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Product containing escitalopram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Escitalopram 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Escitalopram (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Sertraline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Duloxetine (substance) |
Is a |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Zimeldine |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Norfluoxetine |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Desmethylsertraline |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Venlafaxine (substance) |
Is a |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Nefazodone (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Sertraline (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Desvenlafaxine (substance) |
Is a |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Milnacipran |
Is a |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Allergy to selective serotonin re-uptake inhibitor (finding) |
Causative agent (attribute) |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
1 |
Dapoxetine (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
A characteristic selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome is usually mild, commences within 1 week of stopping treatment, resolves spontaneously within 3 weeks, and consists of diverse physical and psychological symptoms, the commonest being dizziness, nausea, lethargy and headache. SSRI reinstatement leads to resolution within 48 hours. |
Causative agent (attribute) |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
1 |
Nefazodone hydrochloride |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Citalopram hydrobromide (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Fluvoxamine maleate |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Venlafaxine hydrochloride |
Is a |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Sertraline hydrochloride |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Fluoxetine hydrochloride |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Citalopram hydrochloride (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Paroxetine hydrochloride |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Paroxetine mesilate |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Duloxetine hydrochloride (substance) |
Is a |
False |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Escitalopram oxalate (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Dapoxetine hydrochloride (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Clopenthixol (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Zuclopenthixol (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Zuclopenthixol dihydrochloride (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Zuclopenthixol acetate (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Zuclopenthixol decanoate (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Paroxetine hydrochloride hemihydrate (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Substance with norepinephrine reuptake inhibitor and serotonin reuptake inhibitor mechanism of action (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Vilazodone (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Vilazodone hydrochloride |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Selective serotonin re-uptake inhibitor dependence |
Causative agent (attribute) |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
1 |
Paroxetine hydrochloride anhydrous (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|
Characterised by persistent sexual side effects that continue after discontinuing selective serotonin re-uptake inhibitors (SSRIs), a class of antidepressants. Symptoms may include reduced libido, erectile dysfunction, anorgasmia (inability to achieve orgasm), genital numbness, and other sexual dysfunctions. These symptoms can last for weeks, months, or even years after stopping the medication. |
Causative agent (attribute) |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
2 |
Paroxetine hydrochloride acetone solvate (substance) |
Is a |
True |
Selective serotonin re-uptake inhibitor |
Inferred relationship |
Some |
|